PMChek
  • Home
  • Login
  • About Us
  • Contact Us
  • Blog
  • Drug Shortages
PMChek
Drug Shortages
Drug Shortages

Drug Shortages reported to us

Drug Shortages can occur because of manufacturing and quality problems, delays and discontinuations.


Sort By: Date | Name


Drug Shortages

Monday, June 16, 2025

  • FDA Ethinyl Estradiol; Etonogestrel Ring .015 mg/1 d; .12 mg/1 d (NDC 00093767902) TEVA PHARMACEUTICALS USA
  • FDA Testosterone Gel; Gel Metered 16.2 mg/1 g (NDC 00591292530) ACTAVIS PHARMA
  • FDA Tobramycin Solution 300 mg/4 mL (NDC 00093375028) TEVA PHARMACEUTICALS USA
  • FDA Tobramycin Solution 300 mg/4 mL (NDC 00093375063) TEVA PHARMACEUTICALS USA
  • FDA Tobramycin Solution 300 mg/5 mL (NDC 00093408563) TEVA PHARMACEUTICALS USA

Friday, June 13, 2025

  • FDA Adipex-P Tablet 37.5 mg (NDC 57844014001) TEVA SELECT BRANDS
  • FDA Adipex-P Tablet 37.5 mg (NDC 57844014056) TEVA SELECT BRANDS
  • FDA AirDuo RespiClick Powder 113 ug; 14 ug (NDC 59310081206) TEVA RESPIRATORY
  • FDA AirDuo RespiClick Powder 232 ug; 14 ug (NDC 59310082206) TEVA RESPIRATORY
  • FDA AirDuo RespiClick Powder 55 ug; 14 ug (NDC 59310080506) TEVA RESPIRATORY
  • FDA Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxom (NDC 13668038230) TORRENT PHARMACEUTICALS
  • FDA Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxom (NDC 13668038290) TORRENT PHARMACEUTICALS
  • FDA Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxom (NDC 13668038530) TORRENT PHARMACEUTICALS
  • FDA Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxom (NDC 13668038590) TORRENT PHARMACEUTICALS
  • FDA Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxom (NDC 13668038630) TORRENT PHARMACEUTICALS
  • FDA Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxom (NDC 13668038690) TORRENT PHARMACEUTICALS
  • FDA Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxom (NDC 13668039730) TORRENT PHARMACEUTICALS
  • FDA Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxom (NDC 13668039790) TORRENT PHARMACEUTICALS
  • FDA Bleomycin Sulfate Injection 15 [USPU] (NDC 00409033220) NOVAPLUS/HOSPIRA
  • FDA Bleomycin Sulfate Injection 30 [USPU] (NDC 00409032320) NOVAPLUS/HOSPIRA
  • FDA Granix Injection 480 ug/1.6 mL (NDC 63459092059) TEVA PHARMACEUTICALS USA
  • FDA Pravastatin Sodium Tablet 10 mg (NDC 00093077110) TEVA PHARMACEUTICALS USA
  • FDA Pravastatin Sodium Tablet 10 mg (NDC 00093077198) TEVA PHARMACEUTICALS USA
  • FDA Pravastatin Sodium Tablet 20 mg (NDC 00093720110) TEVA PHARMACEUTICALS USA
  • FDA Pravastatin Sodium Tablet 20 mg (NDC 00093720198) TEVA PHARMACEUTICALS USA
  • FDA Pravastatin Sodium Tablet 40 mg (NDC 00093720210) TEVA PHARMACEUTICALS USA
  • FDA Pravastatin Sodium Tablet 40 mg (NDC 00093720298) TEVA PHARMACEUTICALS USA
  • FDA Pravastatin Sodium Tablet 80 mg (NDC 00480727010) TEVA PHARMACEUTICALS
  • FDA Pravastatin Sodium Tablet 80 mg (NDC 00480727098) TEVA PHARMACEUTICALS
  • FDA Zovia 1/50E-28 Tablet Kit (NDC 00093807316) TEVA PHARMACEUTICALS USA

Tuesday, June 10, 2025

  • FDA Epitol Tablet 200 mg (NDC 00093009001) TEVA PHARMACEUTICALS USA
  • FDA Epitol Tablet 200 mg (NDC 00093010901) TEVA PHARMACEUTICALS USA
  • FDA Epitol Tablet 200 mg (NDC 00093010910) TEVA PHARMACEUTICALS USA
  • FDA Glyburide Tablet 1.5 mg (NDC 0093-8034-01) (NDC 00093803401) TEVA PHARMACEUTICALS USA
  • FDA Glyburide Tablet 3 mg (NDC 0093-8035-01) (NDC 00093803501) TEVA PHARMACEUTICALS USA
  • FDA Glyburide Tablet 3 mg (NDC 0093-8035-05) (NDC 00093803505) TEVA PHARMACEUTICALS USA
  • FDA Glyburide Tablet 6 mg (NDC 0093-8036-01) (NDC 00093803601) TEVA PHARMACEUTICALS USA

Monday, June 9, 2025

  • FDA Tracleer Tablet 125 mg (NDC 66215010203) ACTELION PHARMACEUTICALS
  • FDA Tracleer Tablet 62.5 mg (NDC 66215010103) ACTELION PHARMACEUTICALS

Wednesday, June 4, 2025

  • FDA Reyataz Capsule 200 mg (NDC 00003363112) B-M SQUIBB U.S. (PRIMARY CARE)
  • FDA Reyataz Capsule 300 mg (NDC 00003362212) B-M SQUIBB U.S. (PRIMARY CARE)
  • FDA Reyataz Oral Powder 50 mg (NDC 00003363810) B-M SQUIBB U.S. (PRIMARY CARE)

Tuesday, June 3, 2025

  • FDA Metoprolol Tartrate Tablet 100 mg (NDC 65862006401) AUROBINDO PHARMA
  • FDA Metoprolol Tartrate Tablet 100 mg (NDC 65862006439) AUROBINDO PHARMA
  • FDA Metoprolol Tartrate Tablet 100 mg (NDC 65862006499) AUROBINDO PHARMA
  • FDA Metoprolol Tartrate Tablet 25 mg (NDC 65862006299) AUROBINDO PHARMA
  • FDA Metoprolol Tartrate Tablet 25 mg (NDC 65862006201) AUROBINDO PHARMA
  • FDA Metoprolol Tartrate Tablet 50 mg (NDC 65862006359) AUROBINDO PHARMA
  • FDA Metoprolol Tartrate Tablet 50 mg (NDC 65862006399) AUROBINDO PHARMA
  • FDA Metoprolol Tartrate Tablet 50 mg (NDC 65862006301) AUROBINDO PHARMA

Friday, May 30, 2025

  • FDA Demerol Injection 100 mg/1 mL (NDC 00409118069) HOSPIRA
  • FDA Demerol Injection 25 mg/1 mL (NDC 00409117630) HOSPIRA
  • FDA Demerol Injection 25 mg/1 mL (NDC 00409136201) HOSPIRA
  • FDA Demerol Injection 50 mg/1 mL (NDC 00409117830) HOSPIRA
  • FDA Demerol Injection 50 mg/1 mL (NDC 00409141801) HOSPIRA
  • FDA Demerol Injection 50 mg/1 mL (NDC 00409118130) HOSPIRA
  • FDA Demerol Injection 75 mg/1 mL (NDC 00409117930) HOSPIRA
  • FDA Meperidine Hydrochloride Injection 100 mg/1 mL (NDC 00641605425) HIKMA PHARMACEUTICALS USA
  • FDA Meperidine Hydrochloride Injection 25 mg/1 mL (NDC 00641605225) HIKMA PHARMACEUTICALS USA
  • FDA Meperidine Hydrochloride Injection 50 mg/1 mL (NDC 00641605325) HIKMA PHARMACEUTICALS USA

Wednesday, May 28, 2025

  • FDA Desowen Cream .5 mg/1 g (NDC 00472080460) ACTAVIS MID ATLANTIC
  • FDA Desowen Cream .5 mg/1 g (NDC 00472080415) ACTAVIS MID ATLANTIC

Friday, May 23, 2025

  • FDA Minocycline Hydrochloride Capsule 75 mg (NDC 00591315301) ACTAVIS PHARMA
  • FDA Nortriptyline Hydrochloride Capsule 75 mg (NDC 00093081305) TEVA PHARMACEUTICALS USA

Monday, May 19, 2025

  • FDA Potassium Chloride Capsule Extended Release 600 mg (NDC 62037055901) ACTAVIS PHARMA
  • FDA Potassium Chloride Capsule Extended Release 600 mg (NDC 62037055905) ACTAVIS PHARMA
  • FDA Potassium Chloride Capsule Extended Release 750 mg (NDC 62037056001) ACTAVIS PHARMA
  • FDA Potassium Chloride Capsule Extended Release 750 mg (NDC 62037056005) ACTAVIS PHARMA
  • FDA Potassium Chloride Capsule Extended Release 750 mg (NDC 62037056010) ACTAVIS PHARMA
  • FDA Potassium Chloride Capsule Extended Release 750 mg (NDC 62037056090) ACTAVIS PHARMA

Wednesday, May 14, 2025

  • FDA Oxybutynin Chloride Tablet 5 mg (NDC 00832003800) UPSHER-SMITH
  • FDA Oxybutynin Chloride Tablet 5 mg (NDC 00832003801) UPSHER-SMITH
  • FDA Oxybutynin Chloride Tablet 5 mg (NDC 00832003810) UPSHER-SMITH
  • FDA Oxybutynin Chloride Tablet 5 mg (NDC 00832003850) UPSHER-SMITH
  • FDA Prevalite Powder 4 g/5.5 g (NDC 00245003623) UPSHER-SMITH
  • FDA Prevalite Powder 4 g/5.5 g (NDC 00245003642) UPSHER-SMITH
  • FDA Prevalite Powder 4 g/5.5 g (NDC 00245003660) UPSHER-SMITH
  • FDA Propafenone Hydrochloride Capsule Extended Release 225 mg (NDC 00832074060) UPSHER-SMITH
  • FDA Propafenone Hydrochloride Capsule Extended Release 325 mg (NDC 00832074160) UPSHER-SMITH
  • FDA Propafenone Hydrochloride Capsule Extended Release 425 mg (NDC 00832074260) UPSHER-SMITH

Important:   Items shown in shortage are based on information provided by wholesalers when they list manufacturer out and discontinued items. Items are shown for 60 days from date of initial insertion on this list.

PMChek® | 1306 Oxbridge Dr, Lutz FL 33549
Copyright (C) 2025 PMChek.com
Home, About Us, Contact Us, Privacy